NCT00851500View on ClinicalTrials.gov

A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions
Atherosclerosis
Interventions
DRUG

K-604

K-604 is given for 26 weeks

OTHER

Placebo

placebo tablets are given for 26 weeks

Trial Locations (19)

Unknown

Chandler

Litchfield Park

Phoenix

Los Angeles

San Diego

Clearwater

Jacksonville

St Louis

Buffalo

Oklahoma City

Carrollton

Dallas

Houston

Plano

Norfolk

Virginia Beach

Olympia

Renton

Seattle

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY